Cargando…

The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019

In China, chronic obstructive pulmonary disease (COPD) was accounted for a quarter of the global COPD population and has become a large economic burden. However, the comprehensive picture of the COPD burden, which could inform health policy, is not readily available for all of the provinces of China...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Peng, Wu, Jiayuan, Wang, Lijun, Luo, Chaole, Ouyang, Lihuan, Tang, Xiantong, Liu, Jiangmei, Liu, Yunning, Qi, Jinlei, Zhou, Maigeng, Lai, Tianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215345/
https://www.ncbi.nlm.nih.gov/pubmed/35757649
http://dx.doi.org/10.3389/fpubh.2022.859499
_version_ 1784731190052257792
author Yin, Peng
Wu, Jiayuan
Wang, Lijun
Luo, Chaole
Ouyang, Lihuan
Tang, Xiantong
Liu, Jiangmei
Liu, Yunning
Qi, Jinlei
Zhou, Maigeng
Lai, Tianwen
author_facet Yin, Peng
Wu, Jiayuan
Wang, Lijun
Luo, Chaole
Ouyang, Lihuan
Tang, Xiantong
Liu, Jiangmei
Liu, Yunning
Qi, Jinlei
Zhou, Maigeng
Lai, Tianwen
author_sort Yin, Peng
collection PubMed
description In China, chronic obstructive pulmonary disease (COPD) was accounted for a quarter of the global COPD population and has become a large economic burden. However, the comprehensive picture of the COPD burden, which could inform health policy, is not readily available for all of the provinces of China. Here, we aimed to describe the burden of COPD in China, providing an up-to-date and comprehensive analysis at the national and provincial levels, and time trends from 1990 to 2019. Following the methodology framework and general analytical strategies used in the GBD 2019, we analyzed the incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years with life lost (YLLs) attributable to COPD across China and the corresponding time trends from 1990 to 2019, stratified by age and province. In order to quantify the secular trends of the burden of COPD, the estimated annual percentage changes were calculated by the linear regression model of age-standardized rates (ASRs) and calendar years. We also presented the contribution of risk factors to COPD-related mortality and DALYs. The association between COPD burden and socio-demographic index (SDI) were also evaluated. From 1990 to 2019, the incidence and prevalence numbers of COPD increased by 61.2 and 67.8%, respectively, whereas the number of deaths and DALYs owing to COPD decreased. The ASRs of COPD burden, including incidence, prevalence, mortality, DALYs, YLDs, and YLLs continuously decreased from 1990 to 2019. The crude rates of COPD burden dramatically increased with age and reached a peak in the older than 95 years age group. In 2019, the leading risk factor for COPD mortality and DALYs was tobacco use in the whole population, but ambient particulate matter pollution was the most significant risk factor in females. At the provincial level, the ASRs of COPD burden was significantly associated with the SDIs, with the highest ASRs in the western provinces with low SDIs. Collectively, our study indicated that COPD remains an important public health problem in China. Geographically targeted considerations should be developed to enhance COPD health and reduce the COPD burden throughout China and in specific provinces.
format Online
Article
Text
id pubmed-9215345
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92153452022-06-23 The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 Yin, Peng Wu, Jiayuan Wang, Lijun Luo, Chaole Ouyang, Lihuan Tang, Xiantong Liu, Jiangmei Liu, Yunning Qi, Jinlei Zhou, Maigeng Lai, Tianwen Front Public Health Public Health In China, chronic obstructive pulmonary disease (COPD) was accounted for a quarter of the global COPD population and has become a large economic burden. However, the comprehensive picture of the COPD burden, which could inform health policy, is not readily available for all of the provinces of China. Here, we aimed to describe the burden of COPD in China, providing an up-to-date and comprehensive analysis at the national and provincial levels, and time trends from 1990 to 2019. Following the methodology framework and general analytical strategies used in the GBD 2019, we analyzed the incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years with life lost (YLLs) attributable to COPD across China and the corresponding time trends from 1990 to 2019, stratified by age and province. In order to quantify the secular trends of the burden of COPD, the estimated annual percentage changes were calculated by the linear regression model of age-standardized rates (ASRs) and calendar years. We also presented the contribution of risk factors to COPD-related mortality and DALYs. The association between COPD burden and socio-demographic index (SDI) were also evaluated. From 1990 to 2019, the incidence and prevalence numbers of COPD increased by 61.2 and 67.8%, respectively, whereas the number of deaths and DALYs owing to COPD decreased. The ASRs of COPD burden, including incidence, prevalence, mortality, DALYs, YLDs, and YLLs continuously decreased from 1990 to 2019. The crude rates of COPD burden dramatically increased with age and reached a peak in the older than 95 years age group. In 2019, the leading risk factor for COPD mortality and DALYs was tobacco use in the whole population, but ambient particulate matter pollution was the most significant risk factor in females. At the provincial level, the ASRs of COPD burden was significantly associated with the SDIs, with the highest ASRs in the western provinces with low SDIs. Collectively, our study indicated that COPD remains an important public health problem in China. Geographically targeted considerations should be developed to enhance COPD health and reduce the COPD burden throughout China and in specific provinces. Frontiers Media S.A. 2022-06-03 /pmc/articles/PMC9215345/ /pubmed/35757649 http://dx.doi.org/10.3389/fpubh.2022.859499 Text en Copyright © 2022 Yin, Wu, Wang, Luo, Ouyang, Tang, Liu, Liu, Qi, Zhou and Lai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Yin, Peng
Wu, Jiayuan
Wang, Lijun
Luo, Chaole
Ouyang, Lihuan
Tang, Xiantong
Liu, Jiangmei
Liu, Yunning
Qi, Jinlei
Zhou, Maigeng
Lai, Tianwen
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
title The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
title_full The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
title_fullStr The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
title_full_unstemmed The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
title_short The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
title_sort burden of copd in china and its provinces: findings from the global burden of disease study 2019
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215345/
https://www.ncbi.nlm.nih.gov/pubmed/35757649
http://dx.doi.org/10.3389/fpubh.2022.859499
work_keys_str_mv AT yinpeng theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT wujiayuan theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT wanglijun theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT luochaole theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT ouyanglihuan theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT tangxiantong theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT liujiangmei theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT liuyunning theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT qijinlei theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT zhoumaigeng theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT laitianwen theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT yinpeng burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT wujiayuan burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT wanglijun burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT luochaole burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT ouyanglihuan burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT tangxiantong burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT liujiangmei burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT liuyunning burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT qijinlei burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT zhoumaigeng burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019
AT laitianwen burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019